153 related articles for article (PubMed ID: 9834102)
1. FLT3-ligand administration inhibits liver metastases: role of NK cells.
Péron JM; Esche C; Subbotin VM; Maliszewski C; Lotze MT; Shurin MR
J Immunol; 1998 Dec; 161(11):6164-70. PubMed ID: 9834102
[TBL] [Abstract][Full Text] [Related]
2. Expansion of functional NK cells in multiple tissue compartments of mice treated with Flt3-ligand: implications for anti-cancer and anti-viral therapy.
Shaw SG; Maung AA; Steptoe RJ; Thomson AW; Vujanovic NL
J Immunol; 1998 Sep; 161(6):2817-24. PubMed ID: 9743341
[TBL] [Abstract][Full Text] [Related]
3. IFN-gamma-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effects.
Osaki T; Péron JM; Cai Q; Okamura H; Robbins PD; Kurimoto M; Lotze MT; Tahara H
J Immunol; 1998 Feb; 160(4):1742-9. PubMed ID: 9469432
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cells engineered to express the Flt3 ligand stimulate type I immune response, and induce enhanced cytoxic T and natural killer cell cytotoxicities and antitumor immunity.
Liu Y; Huang H; Chen Z; Zong L; Xiang J
J Gene Med; 2003 Aug; 5(8):668-80. PubMed ID: 12898636
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-12 and Flt3 ligand differentially promote dendropoiesis in vivo.
Esche C; Cai Q; Peron JM; Hunter O; Subbotin VM; Lotze MT; Shurin MR
Eur J Immunol; 2000 Sep; 30(9):2565-75. PubMed ID: 11009090
[TBL] [Abstract][Full Text] [Related]
6. T cell- and NK cell-independent inhibition of hepatic metastases by systemic administration of an IL-12-expressing recombinant adenovirus.
Siders WM; Wright PW; Hixon JA; Alvord WG; Back TC; Wiltrout RH; Fenton RG
J Immunol; 1998 Jun; 160(11):5465-74. PubMed ID: 9605149
[TBL] [Abstract][Full Text] [Related]
7. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively.
Hashimoto W; Osaki T; Okamura H; Robbins PD; Kurimoto M; Nagata S; Lotze MT; Tahara H
J Immunol; 1999 Jul; 163(2):583-9. PubMed ID: 10395644
[TBL] [Abstract][Full Text] [Related]
8. Effect of vascular endothelial growth factor and FLT3 ligand on dendritic cell generation in vivo.
Ohm JE; Shurin MR; Esche C; Lotze MT; Carbone DP; Gabrilovich DI
J Immunol; 1999 Sep; 163(6):3260-8. PubMed ID: 10477595
[TBL] [Abstract][Full Text] [Related]
9. Antitumor effect of alpha-galactosylceramide (KRN7000) on spontaneous hepatic metastases requires endogenous interleukin 12 in the liver.
Fuji N; Ueda Y; Fujiwara H; Toh T; Yoshimura T; Yamagishi H
Clin Cancer Res; 2000 Aug; 6(8):3380-7. PubMed ID: 10955826
[TBL] [Abstract][Full Text] [Related]
10. IL-12 cDNA direct injection: antimetastatic effect from a single injection in a murine hepatic metastases model.
Weber SM; Qi C; Neal Z; Sondel P; Mahvi DM
J Surg Res; 2004 Dec; 122(2):210-7. PubMed ID: 15555620
[TBL] [Abstract][Full Text] [Related]
11. Cellular mechanisms of interleukin-12-mediated neuroblastoma regression.
Redlinger RE; Shimizu T; Remy T; Alber S; Watkins SC; Barksdale EM
J Pediatr Surg; 2003 Feb; 38(2):199-204. PubMed ID: 12596103
[TBL] [Abstract][Full Text] [Related]
12. FLT3 ligand induces the generation of functionally active dendritic cells in mice.
Shurin MR; Pandharipande PP; Zorina TD; Haluszczak C; Subbotin VM; Hunter O; Brumfield A; Storkus WJ; Maraskovsky E; Lotze MT
Cell Immunol; 1997 Aug; 179(2):174-84. PubMed ID: 9268501
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the functional properties of murine dendritic cells generated in vivo with Flt3 ligand, GM-CSF and Flt3 ligand plus GM-SCF.
Daro E; Butz E; Smith J; Teepe M; Maliszewski CR; McKenna HJ
Cytokine; 2002 Feb; 17(3):119-30. PubMed ID: 11895330
[TBL] [Abstract][Full Text] [Related]
14. In vivo administration of flt3 ligand markedly stimulates generation of dendritic cell progenitors from mouse liver.
Drakes ML; Lu L; Subbotin VM; Thomson AW
J Immunol; 1997 Nov; 159(9):4268-78. PubMed ID: 9379022
[TBL] [Abstract][Full Text] [Related]
15. Synergistic action of fms-like tyrosine kinase 3 ligand and CD40 ligand in the induction of dendritic cells and generation of antitumor immunity in vivo.
Borges L; Miller RE; Jones J; Ariail K; Whitmore J; Fanslow W; Lynch DH
J Immunol; 1999 Aug; 163(3):1289-97. PubMed ID: 10415026
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus-interleukin-12-mediated tumor regression in a murine hepatocellular carcinoma model is not dependent on CD1-restricted natural killer T cells.
Andrews KJ; Ribas A; Butterfield LH; Vollmer CM; Eilber FC; Dissette VB; Nelson SD; Shintaku P; Mekhoubad S; Nakayama T; Taniguchi M; Glaspy JA; McBride WH; Economou JS
Cancer Res; 2000 Nov; 60(22):6457-64. PubMed ID: 11103813
[TBL] [Abstract][Full Text] [Related]
17. Administration of interleukin-12 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines in mouse hepatocellular carcinoma.
Tatsumi T; Takehara T; Kanto T; Miyagi T; Kuzushita N; Sugimoto Y; Jinushi M; Kasahara A; Sasaki Y; Hori M; Hayashi N
Cancer Res; 2001 Oct; 61(20):7563-7. PubMed ID: 11606395
[TBL] [Abstract][Full Text] [Related]
18. Combination treatment with IL-2 and anti-IL-2 mAbs reduces tumor metastasis via NK cell activation.
Jin GH; Hirano T; Murakami M
Int Immunol; 2008 Jun; 20(6):783-9. PubMed ID: 18448458
[TBL] [Abstract][Full Text] [Related]
19. FLT3 ligand administration inhibits tumor growth in murine melanoma and lymphoma.
Esche C; Subbotin VM; Maliszewski C; Lotze MT; Shurin MR
Cancer Res; 1998 Feb; 58(3):380-3. PubMed ID: 9458075
[TBL] [Abstract][Full Text] [Related]
20. Endogenous and adoptively transferred A-NK and T-LAK cells continuously accumulate within murine metastases up to 48 h after inoculation.
Hokland M; Kjaergaard J; Kuppen PJ; Nannmark U; Agger R; Hokland P; Basse P
In Vivo; 1999; 13(3):199-204. PubMed ID: 10459491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
